Search Results

1-20 of 643 results for subject:"Medical treatments"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

Hunt of Kings Heath, Lord

What plans they have for tackling variations in access to treatment for infertility. [HL

Asked by

Baroness Howells of St Davids (Labour)

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

619 c178WA

House

House of Lords

Dept of Health

To ask the Secretary of State for Health, if he will take steps to ensure that Visudyne is made available to NHS patients.

Asked by

David Amess (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c892W; 140575

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has for tackling variations in access to treatment for infertility; and if he will make a statement. - Inc ref to baseline survey of infertility services in the National Health Service in 1997 to be placed in Library.

Asked by

Sally Keeble (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c895W; 141284

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on his policy towards the access to treatment by the NHS for war pensioners. - Inc ref to Health Service Guidance 97/31, in Library.

Asked by

Jacqui Lait (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c893W; 141010

House

House of Commons

Ministry of Defence

To ask the Secretary of State for Defence, pursuant to his Answer of 16th November 2000 at 356 c741W, on mustard gas and pigs, whether the company testing the model cream for treating mustard gas burns is a British company; whether untreated controls are being run; and how many and...

Asked by

Derek Wyatt (Labour)

Answering body

Ministry of Defence

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c721-2W;357 c721W; 140725

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, by what means UK residents travelling abroad are informed about charges for healthcare in other countries. - Inc ref to 'Health ADvice for Travellers, in Library.

Asked by

Fiona Mactaggart (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c896W; 141045

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to make Zanamirin available over the counter in pharmacies for self treatment of influenza.

Asked by

Baroness Tonge (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c896W; 140827

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what contra-indications there are to healthy adults taking Zanamivir for influenza.

Asked by

Baroness Tonge (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 November 2000

Reference

357 c895-6W; 140826

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what measures are in place to ensure that additional funds allocated to health authorities to meet the cost of treatments recommended by the National Institute for Clinical Excellence are used solely for that purpose.

Asked by

David Amess (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

29 November 2000

Reference

357 c632W;357 c631W; 140580

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what NHS provision is planned for the diagnosis of and research into Ehlers-Danlos Syndrome after the closure of MRC Connective Tissue Genetics Group in Cardiff; and where a practitioner who suspects Ehlers-Danlos Syndrome in a patient will refer the patient after November;...

Asked by

Baroness McIntosh of Pickering (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

29 November 2000

Reference

357 c629-30W;357 c628W; 137202;137203

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many NHS Lithotriptor machines are available per head of population in each region of England and Wales; and where they are located. - Inc figures.

Asked by

Lord Brady of Altrincham (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

29 November 2000

Reference

357 c631W;357 c630W; 140161

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will list for each of the last 10 years for which figures are available the amount spent on research into (a) Parkinson's disease and (b) stem cell therapy; and if he will make a statement. - Inc table and figures.

Asked by

Lord Jones of Cheltenham (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

15 November 2000

For answer on

29 November 2000

Answered on

29 November 2000

Mr. Nigel Jones: To ask the Secretary of State for Health if he will list for each of the last 10 years for which figures are available the amount spent on research into (a) Parkinson's disease and (b) stem cell therapy; and if he will make a statement. [139280] Mr. Denham: The main Government agency for research into the causes of and treatments for disease is the Medical Research Council (MRC) which receives its funding via the Department of Trade and Industry. The Department of Health funds research to support policy and the delivery of effective practice in the National Health Service. The Department also provides NHS support funding for research commissioned by the research councils and charities that takes place in the NHS. The estimated expenditure figures available for directly commissioned research into Parkinson's disease and stem cell therapy are as shown. They include Medical Research Council and Department of Health support: £ million _________________________________________________________________________________________________. Parkinson's disease Stem cell therapy and related basic research 1995-96 1.7 2.5 1996-97 1.7 2.2 1997-98 1.8 2.1 1998-99 1.8 2.4 1999-2000 1.9 2.4 _________________________________________________________________________________________________. The stem cell research undertaken by the MRC involves mainly projects relating to stem cell transfer involving adult stem cells, for example in the treatment of leukaemia using bone marrow transplantation, which the MRC have been undertaking successfully for many years. In addition, the MRC has funded basic research into the development of animal embryos and the properties of stem cells--involving mostly mouse embryos--which, along with studies of human reproduction, informs current assessments of the potential for new stem cell therapies. None of this work involves specially created human embryos or the use of human cells for cell nuclear transfer. In addition, the Biotechnology and Biological Science Research Council has a diverse programme of research in the basic science of stem cells, potentially underpinning therapeutic applications, which has involved about £15 million of expenditure over the last 10 years.

Date

29 November 2000

Reference

357 c630W;357 c628-9W; 139280

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how much was spent annually by his Department on (a) research into the prevention of accidental injuries and (b) public awareness campaigns to prevent accidental injuries in each of the last five years; and what the costs to the NHS were of...

Asked by

Caroline Spelman (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

23 November 2000

For answer on

28 November 2000

Answered on

28 November 2000

Mrs. Spelman: To ask the Secretary of State for Health how much was spent annually by his Department on (a) research into the prevention of accidental injuries and (b) public awareness campaigns to prevent accidental injuries in each of the last five years; and what the costs to the NHS were of treating accidental injuries in the same period. [140666] Ms Stuart: The main Government agency for health related research is the Medical Research Council (MRC) which receives its funding via the Department for Trade and Industry. The Department of Health funds research to support policy and the delivery of effective practice in the National Health Service. For the last five years the combined funding by these bodies into the prevention of accidental injuries was as follows. _________________________________________________________________________________________________. Date £ 1996-97 {1}17,305 1997-98 366,068 1998-99 702,412 1999-2000 682,954 2000-01 {1}46,302 _________________________________________________________________________________________________. {1} Department of Health only Over the last five years the Department has run several campaigns to prevent accidental injuries. Spending in those years when campaigns were run was as follows : _________________________________________________________________________________________________. Date £ 1997-98 108,000 1998-99 78,494 1999-2000 {1}212,530 2000-01 123,000 _________________________________________________________________________________________________. {1} budget The annual cost to the NHS of treating accidental injuries has been estimated at about £1.6 billion each year (Saving Lives: Our Healthier Nation 1999).

Date

28 November 2000

Reference

357 c559-60W; 140666

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent reviews his Department has made of the use of the drug secretin for treating sufferers of autism; and if he will make a statement. - Including ref to New England Journal of Medicine, 9 December 1999, volume 341, number 24.

Asked by

Margaret Ewing (Scottish National Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

28 November 2000

Reference

140747; 357 c559W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, by what means his Department (a) monitors and (b) evaluates medical research undertaken elsewhere in the world.

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

22 November 2000

For answer on

28 November 2000

Answered on

28 November 2000

Mr. Burstow: To ask the Secretary of State for Health by what means his Department (a) monitors and (b) evaluates medical research undertaken elsewhere in the world. [140543] Ms Stuart: The Department has established mechanisms for monitoring and evaluating medical research undertaken elsewhere in the world. In general, this is an ongoing activity and is part of the day-to-day work of many officials particularly in-house scientists and doctors who are sometimes national and international experts themselves. It is also part of the remit of many of the Department's advisory committees to advise on new scientific discoveries and to present recommendations for further research. The Department is able to call on advice from the Medical Research Council which itself maintains close contact with the progress and implications of medical research around the world. In addition, there are four specific mechanisms. The National Horizon Scanning Centre (NHSC) at the University of Birmingham provides advance notice to the Department of new and emerging health technologies that might require urgent evaluation, consideration of clinical and cost impact or modification of clinical guidance. Health technologies include pharmaceuticals, medical devices, diagnostic tests and procedures, surgery, rehabilitation and health promotion activities. The NHSC hosts the Secretariat for EuroScan, the European Information Network on New and Changing Health Technologies. EuroScan was developed to explore the potential for and benefits of sharing information on selected emerging health technologies or new applications of existing ones. The United Kingdom Cochrane Centre has the overall purpose of facilitating and co-ordinating reviews primarily in the specialised area of randomised controlled trials of health care. Cochrane Reviews place an emphasis on completeness and continuous updating. They are extremely thorough and put a lot of work into identifying relevant research from around the world. The UK Cochrane Centre helped establish the Cochrane Collaboration, which is an independent, international organisation that aims to help people make well informed decisions about health care by preparing, maintaining and promoting the accessibility of systematic reviews of the effects of healthcare interventions. The Cochrane Reviews are undertaken by Collaborative Review Groups (CRGs) comprising experts in particular fields from all over the world. The Centre for Reviews and Dissemination (CRD) commissions and supports experts to undertake specific systematic reviews in areas of priority to the National Health Service. In conducting reviews, the UK Cochrane Centre and CRD work closely together and take account of all work relevant to their area, including work funded in this country by organisations other than the NHS, and work undertaken overseas. The CRD also maintains the Database of Abstracts of Reviews of Effectiveness (DARE) which contains approximately 500 abstracts of systematic reviews. The NHS Health Technology Assessment (HTA) Programme is a national programme of research funded by the Department's research and development programme. The purpose of the programme is to ensure that high quality research information on the cost, effectiveness and broader impact of health technologies available to those who use, manage and provide care in the NHS. The National Co-ordinating Centre for HTA (NCCHTA), which is part of the Wessex Institute for Health Research and Development at the University of Southampton, co-ordinates the HTA programme on behalf of the research and development programme. Much of the work of the programme comprises systematic reviews of the worldwide literature on particular topics. The HTA Programme maintains links with international HTA organisations such as the International Network of Agencies for Health Technology Assessment and the International Society of Technology Assessment in Health Care. There is also close collaboration between the NCCHTA and other international agencies. In particular, NCCHTA works closely with the UK Cochrane Centre, the Cochrane Collaboration and the Centre for Reviews and Dissemination to ensure co-ordination between these related activities.

Date

28 November 2000

Reference

357 c560-1W; 140543

House

House of Commons

Hunt of Kings Heath, Lord

What progress has been made with their views of the commissioning of specialised services in the National Health Service and of the neurosurgery for Parkinson's Disease; and whether they are now in a position to implement their proposals relating to long-term service agreements and regional consortia. [HL 4652].

Asked by

Lord Walton of Detchant (Crossbench)

Type

Written questions

Status

Answered

Date

27 November 2000

Reference

HL 4652; 619 c107-8WA

House

House of Lords

Consultants contracts. Government response to the Health Select Committees third report of session 1999/2000 (HC 586).

Type

Select Committee reports (Government responses); Command papers

Notes

Received 24.11.00

Date

27 November 2000

Reference

Cm 4930

House

House of Commons

Observations by the Parliamentary Under Secretary of State for Health on the petition of 13 November 2000 from cleft lip and/or palate NHS patients and others calling for a quality audit of cleft lip and palate services. (Circulated with the Vote of 28 November 2000)

Lead member

Alan Milburn

Department

Department of Health

Type

Observations on petitions

Date

27 November 2000

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on progress in implementing the Calman-Hine proposals for cancer care; and if he will make a statement.

Asked by

Andrew Love (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 November 2000

Reference

357 c468W; 139429

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, when it was decided that the Northern Centre for Cancer Treatment in Newcastle required replacement; how many radiotherapy cancer treatment machines were available at that time, and what their ages and downtimes were; how many radiotherapy cancer treatment machines are available; and...

Asked by

Jim Cousins (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 November 2000

Reference

357 c473W; 140537

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher